Form EFFECT Acurx Pharmaceuticals,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 11, 2026 4:01 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anne Therese Aesthetic Medicine Operates Four Sites in Ohio and Florida
- SOL Price Today: Solana Bulls Reclaim $100 as Apeing’s Upcoming Crypto Presale Targets Early Movers With 10,000% ROI
- Anne Therese Offers DiamondGlow and Aquagold at 4 Locations
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share